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Dreduced crossovers in the OPCAB group (3.8% vs 7.9%,
P ¼ .081), because of the study design that reduced proce-
dural crossovers resulting from technical problems. The
greater rate of conversion to other treatment in the ECC
group was not related to the surgical technique but mainly
to anatomic reasons, such as a severely diseased ascending
aorta, a frequent finding in this patient population.
Study Limitations
The present on-off was a sponsored study. However, to re-
duce the risk of bias, the outcomes were assessed by an in-
dependent clinical events committee composed of 3
physicians with a relevant medical background in the field
of cardiac surgery (whowere unaware of the allocated treat-
ment). The sponsor’s biostatistician performed blinded anal-
yses of the primary end point, receiving data with a coded
indication of the randomized group assigned to each patient.
CONCLUSIONS
In high-risk patients (euroScore of 6), OPCAB reduces
early mortality and morbidity (MI, neurologic complica-
tions, renal failure, reoperation for bleeding, ARDS) com-
pared with ECC.
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Dr Joseph F. Sabik (Cleveland, Ohio). I would like to congrat-
ulate Dr Lemma and colleagues on a fine presentation and study
and thank them for providing me with a copy of their manuscript
and presentation in advance of the meeting.
I have 3 questions. In this study, 411 patients were entered, how-
ever, you do not tell us how many patients were screened and, of
those screened, what percentage were eligible and, of those eligi-
ble, what percentage were actually enrolled in the study. This in-
formation is important in deciding what percentage of patients
undergoing coronary surgery this study is applicable to and to
whether it is representative of most patients with a euroScore of
6 or higher. Can you provide this information?
My second question is, the study was designed as an expertise-
based randomized controlled trial. In other words, as you
explained, if a patient was randomized to off-pump surgery, his sur-
gery was performed by an expert in off-pump surgery, and if the pa-
tientwas randomized toon-pumpsurgery, his surgerywasperformed
by an expert in on-pump surgery. Therefore, in addition to being ran-
domized to 2 different procedures, the patients were randomized to 2
different groups of surgeons. How can we determine whether the
better outcomes observed in the off-pump patients were because of
off-pump surgery being better or the possibility that the off-pump
surgeonswere better surgeons and therefore their patients did better?
My final question has to do with revascularization. Similar to
other studies comparing on- and off-pump surgery, fewer bypass
grafts were performed in the off-pump surgery group. This is par-
ticularly alarming, because this study is an expertise-based study.
This suggests that off-pump surgery, even in expert hands, might
be a less-effective revascularization strategy than on-pump sur-
gery. Understanding the importance of the completeness of revas-
cularization on long-term outcomes, do the better early outcomes
in off-pump surgery justify the potential long-term risk?
Thank you very much.
Dr Lemma. Thank you very much, Dr Sabik, for your com-
ments. About your first question, we do not know precisely how
many patients were screened and how many were eligible as a di-
rect consequence of the study design. The on-off study was an ex-
pertise-based trial run by consultants working in group practices.
This means that we had plenty of screened and eligible patients
but only a few of them could be randomized because the study pro-
tocol required the simultaneous presence of 2 consultants for the
same patient, 1 an expert in off-pump and 1 an expert in on-
pump surgery at the moment of envelope opening in the operating
room. In a few hospitals, these data were not always recorded so I
can’t give you figures. This is also the reason the study took
roughly 4 years to be completed.ery c March 2012
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DDr Sabik. Can I ask a follow-up. Do you have an idea of what
percentage of patients undergoing surgery have a euroScore
greater than 6? Is it 5%, 10%, 20%?
Dr Lemma. I don’t know precisely the figure how many pa-
tients had a euroScore greater than 6 among the screened and eli-
gible patients. I can tell you that the average euroScore was 8 in
both groups, on-pump and off-pump patients.
About the question related to the number of distal anastomoses,
this is an interesting point in the sense that we had 3.0 distal anas-
tomoses in the off-pump group and 3.3 in the on-pump group.
However, if you consider the difference between the planned ver-
sus performed distal anastomoses, in the off-pump group, the num-
ber of distal anastomoses performed was equal to the number of
distal anastomoses predicted, but in the on-pump group, the num-
ber of distal anastomoses performed was greater than the number
of distal anastomoses predicted. Thus, it seems that there was an
attitude in the on-pump group to perform more distal anastomoses
than predicted before the operation.
And the last question was?
Dr Sabik. Something we don’t often see in surgery is an exper-
tise-based trial. It obviously adds the confounder of different sur-
gical groups.
Dr Lemma. Well, I would see the problem the other way
around in the sense that expertise-based studies are important be-
cause only an expert surgeon can precisely apply a given surgical
technique. Moreover, in an expertise-based study, you do not have
a surgeons who can be consciously or unconsciously biased toward
a treatment, because they do believe the treatment they apply is the
best. If you consider other prospective randomized trials, such as
the Best Bypass Surgery study published recently in the journal
Circulation, they enrolled 3 surgeons who performed both on-
pump and off-pump surgery. However, we can’t imagine that
they were neutral toward these 2 procedures. For sure, they pre-
ferred 1 of these 2, and so they could have consciously or uncon-
sciously been biased toward 1 of these 2 treatments. In our study,
the surgeons couldn’t be biased, either consciously or uncon-
sciously, toward on-pump or off-pump surgery because they be-
lieved the treatment they applied was the best one.
Dr Sabik. Thank you.
Dr Lokeswara Rao Sajja (Hyderabad, India). I congratulate
Dr Lemma for an excellently designed and executed study. I
have a couple of questions. In your study, was the preoperative se-
rum creatinine level comparable between the 2 groups? Because
even a marginal increase in the preoperative creatinine in 1 group
can lead to an increased incidence of postoperative renal failure
in that group. I also find that in the intention-to-treat analysis, there
was no significant difference in the incidence of renal failure be-
tween the ECC group and the OPCAB group, but the in on-treat-
ment analysis, there was a significant difference. Is this
difference due to the conversion of the cases fromOPCAB to ECC?
Dr Lemma. Thank you for your question. There was no differ-
ence between the 2 groups in the renal function. The only differences
among the preoperative clinical characteristics were in age—we had
older patients in the off-pump group—and myocardial infarction, of
which we had a greater incidence in the on-pump group.
After on-treatment analysis, which means considering cross-
overs, renal function became statistically significant, per se. This
probably means that the hemodynamic stability of off-pumpThe Journal of Thoracic and Casurgery was ideal to preserve renal function, but in the on-pump
group, the continuous flow due to the pump probably decreased
the function of the patient with preoperative borderline renal
function.
Dr Sajja. It is presented that reoperation for postoperative
bleeding was significantly greater in the ECC group. Was the pro-
tocol to stop antiplatelet drug therapy uniform in both the groups?
Were the patients on single antiplatelet or dual-antiplatelet therapy
before the patients were subjected to surgery?
Dr Lemma. The antiplatelet protocol was the same in both
groups. The patients usually stopped antiplatelets at least 5 days
before surgery.
Dr John D. Puskas (Atlanta, Ga). Dr Lemma, I congratulate
you on a landmark study in off-pump bypass, a subject near and
dear to my own heart. It is interesting to see this expertise-based
randomization strategy. I do believe it is an important way to
look at this problem of comparing off-pump and on-pump bypass.
Certainly, the failure to do that sort of equivalence of expertise in
both surgical groups in the Randomized On/Off Bypass trial was
a fundamental flaw of that trial, and you have avoided that with
your design. I have 3 questions.
You commented on the completeness of revascularization, that
is, the number of grafts performed versus planned having been dif-
ferent between the groups. Was the completeness of revasculariza-
tion accomplished in the lateral wall in the off-pump group? That
is where the rubber hits the road. Were your surgeons able to graft
the lateral wall effectively and completely in the off-pump group?
Was the extra graft or 0.3 of a graft in the on-pump group sort of
a gratuitous extra diagonal graft by a motivated team of on-
pump surgeons?
The second question, was the use of arterial conduits similar be-
tween the groups?
Finally, can you share with us any information about the length
of stay or cost comparisons between these 2 groups?
Again, congratulations on a terrific study.
Dr Lemma.Well, I don’t have an answer for your last question
in the sense that a cost-comparison analysis was not planned in the
study design, and the length of stay was a part of secondary end
point analysis. Thus, these data will be analyzed in conjunction
with 1 year of follow-up. About the question of whether in the
off-pump group, also the obtuse marginal branch was easily by-
passed, the answer is yes. If you consider the data, 70% of surgeons
routinely used a heart positioner and 90% routinely used intracoro-
nary shunts. This means that according to the principles espoused
by Paul Sergeant in his Web site related to the teachable compo-
nents of off-pump surgery, the surgeons were able to maintain
a perfect hemodynamic stability throughout the operation without
any problem bypassing the obtuse marginal branch.
And the second question, Dr Puskas, was?
Dr Puskas. Arterial grafting. Was the use of arterial conduits
similar between the groups and what was the use of arterial
conduits?
Dr Lemma. No difference was found between the use of arte-
rial conduits in the 2 groups, neither as number nor as type. The
only difference was in the number of venous grafts, it was greater
in the on-pump group, as you said probably a sort of gratuitous ex-
tra graft by a motivated team of on-pump surgeons.
Dr Puskas. Thank you.rdiovascular Surgery c Volume 143, Number 3 631
